Settlement of legal proceedings with Pall Corporation
25 Sep 2006
Nottingham, UK, 25 September 2006: Innovata plc (LSE IOV) announces that the legal proceedings between Quadrant (a subsidiary of Innovata) and Pall Corporation have been settled on confidential terms, with each side withdrawing their claims.
Contacts:
| Innovata plc | Tel: 0115 974 7474 |
| Kieran Murphy, Chief Executive Officer | |
| Peter Shennan, Finance Director | |
| Financial Dynamics | Tel. 020 7831 3113 |
| Sarah MacLeod/Anna Keeble |
Notes to Editors
Innovata plc
Innovata plc specialises in the development of pulmonary products for the treatment of respiratory disorders and other serious diseases. Using its proprietary dry powder inhaler and drug formulation technologies, the company has developed a pipeline of revenue-generating/marketed and clinical-stage products. In addition, the company has a portfolio of non-pulmonary products with growing revenues. Innovata has established development and marketing partnerships with a number of pharmaceutical companies including Baxter, Merck KGaA, UCB and Otsuka. For further information, please see www.innovataplc.com.
